Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Aplasia Pure Red Cell

ribavirin has been researched along with Aplasia Pure Red Cell in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kami, M; Komatsu, T; Miura, Y; Toda, N; Yotsuya, R1
Kato, M; Miura, H; Ryu, T; Saito, T; Yamada, H1
Chang, CS; Lin, HY; Tsai, CY; Yan, SL; Yu, FL1
Ishida, F; Tanaka, E; Tanaka, N1
Hodo, Y; Honda, M; Kaneko, S; Mizukoshi, E; Nakamoto, Y; Sakai, A; Tsuji, K; Yamashita, T1
Alobeid, B; Gaglio, PJ; Mears, JG; Schecter, JM1

Other Studies

6 other study(ies) available for ribavirin and Aplasia Pure Red Cell

ArticleYear
Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.
    American journal of hematology, 2008, Volume: 83, Issue:9

    Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Red-Cell Aplasia, Pure; Ribavirin

2008
[Peginterferon alfa-2b and ribavirin-induced pure red cell aplasia during treatment of chronic hepatitis C treated by cyclosporin A with good response].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2008, Jul-10, Volume: 97, Issue:7

    Topics: Administration, Inhalation; Antiviral Agents; Cyclosporine; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Red-Cell Aplasia, Pure; Ribavirin

2008
Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C.
    World journal of gastroenterology, 2011, Apr-28, Volume: 17, Issue:16

    Topics: Aged; Antiviral Agents; Bone Marrow Cells; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Red-Cell Aplasia, Pure; Ribavirin

2011
Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C.
    The New England journal of medicine, 2004, Mar-18, Volume: 350, Issue:12

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Red-Cell Aplasia, Pure; Ribavirin

2004
Pure red cell aplasia associated with concomitant use of mycophenolate mofetil and ribavirin in post-transplant recurrent hepatitis C.
    Transplant international : official journal of the European Society for Organ Transplantation, 2006, Volume: 19, Issue:2

    Topics: Antiviral Agents; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Recurrence; Red-Cell Aplasia, Pure; Ribavirin

2006
Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:11

    Topics: Anemia; Antibodies; Antiviral Agents; Epoetin Alfa; Erythropoietin; Graft Rejection; Hematinics; Hepatitis C; Humans; Immunocompromised Host; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Prednisone; Recombinant Proteins; Red-Cell Aplasia, Pure; Ribavirin; Secondary Prevention; Tacrolimus

2007